Chapter I · Title band

Levonor Levonorgestrel 0,75 mg 2 Tabletas enriquecido-2026-06-13 o según indicación profesional 4097

Name: Levonor Levonorgestrel 0,75 mg 2 Tabletas enriquecido-2026-06-13 o según indicación profesional 4097
Brand: growinghearts.net
SKU: 52014927403
Price: 8500.00 USD
Availability: InStock
Rating: 4.1197 (26 reviews)

SKU 52014927403 · ★ 4.1

Chapter II · Gallery

Levonor Levonorgestrel 0,75 mg 2 Tabletas enriquecido-2026-06-13 o según indicación profesional 4097

Chapter III · Acquire

EUR8500.00 EUR8522.00

Pay in 4 interest-free payments of $2125.00 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 22 - Oct 27

Court notes

Description

Levonor Levonorgestrel 0,75 mg 2 Tabletas enriquecido 2026 06 13 o según indicación profesional 4097 o según indicación profesional Venosmil (Hidrosmina) Indicación: Anticoncepción de emergencia para prevenir el embarazo no deseado tras una relación sexual sin protección o fallo anticonceptivo máxima eficacia hasta 120 horas) y la segunda 12 horas después

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Frequently Asked Questions for Levonor Levonorgestrel 0,75 mg 2 Tabletas enriquecido-2026-06-13 o según indicación profesional 4097

How can I get useful help from the seller about a product or order?

Include the relevant listing wording if you are asking about an ambiguous claim. Check whether a separate contact is designated for a particular order issue.

How can I decide whether this product meets my needs?

Think about whether a simpler option would meet the same need. Consider any additional requirements needed to get the intended benefit.

What should I record if a purchase-related problem happens only sometimes?

Record changes to the arrangement that might provide useful context. Avoid submitting repeated identical reports without additional relevant information.